Merck & Co., Inc. (MRK)
Last updated: 2026-11-17 23:58:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Merck & Co., Inc. (MRK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $143.29, with a market capitalization of $364.26B and a P/E ratio of 145.18. Over the past 52 weeks, its price has ranged from $92.11 to $156.92. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$364.26B | |
$143.32 | |
$145.05 | |
$142.37 | |
$144.46 | |
5.37M | |
10.27M | |
145.18 | |
$156.92 | |
$92.11 | |
2.35% | |
-- |
Merck & Co., Inc. (MRK) After-Hours Stock Price
Merck & Co., Inc. (MRK) is trading at $142.99 in after-hours trading as of 2026-11-17 23:55:00, down 0.22% ($0.31) from the regular-session close of $143.29.
After-hours trading shows how investors are pricing MRK after the regular session closes. The current after-hours price is near the regular-session close, indicating cautious after-hours sentiment.
Merck & Co., Inc. (MRK) 7-Day Stock Price Change
Over the past seven days, Merck & Co., Inc. (MRK) moved from $146.73 to $143.29, representing a decline of 2.34% ($3.44).
The stock traded between $142.37 and $149.31 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 6.91 million shares, down versus the previous seven-day period, indicating lower trading activity.
MRK 52-Week Price Position
Position in Range: 79.0%
MRK is currently trading at $143.29, placing it 79.0% of the way from its 52-week low of $92.11 to its 52-week high of $156.92. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Merck & Co., Inc. (MRK)?
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Merck & Co., Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 75,000 |
| Exchange | NYSE |
| Company Website |
MRK Stock Events
View the latest dividend and stock split events for Merck & Co., Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Sep 15, 2026 |
| Payment Date | Oct 7, 2026 |
| Dividend Per Share | $0.85 |
MRK News
Latest news related to Merck & Co., Inc. and MRK stock.
- Read Full Article
- Read Full Article
Cancer Vaccines Clinical Trial Pipeline Boom as 200+ Companies are in the Race for Better Treatments | DelveInsight
Over 200 companies are advancing cancer vaccine development with 200+ pipeline candidates in clinical trials. Recent positive Phase III results for intismeran autogene (mRNA-4157) in melanoma and encouraging data for TG4050 in head and neck cancer are driving momentum. However, challenges including clinical efficacy uncertainties, manufacturing complexity, high production costs, and patient selection barriers remain obstacles to broader commercialization.
- Read Full Article
Merck Raises Quarterly Dividend From $0.85 To $0.88/Share
- Read Full Article
Eli Lilly Short Interest Rises, Remains Below August Peak
Eli Lilly and Co. (NYSE:LLY) short sellers added to their positions, with the latest report following the company’s Q3 2026 earnings release.Short interest rose 3.64% to 7.21 million shares as of the Oct. 30 settlement
- Read Full Article
Biotechnology Market Companies 2027 Analysis: Amgen, Gilead, Regeneron, Vertex and Moderna Post Strong 2026 Results as Billion-Dollar Deals Reshape a Market Headed for USD 6.34 Trillion by 2035
The global biotechnology market, valued at USD 2.02 trillion in 2026, is projected to reach USD 6.34 trillion by 2035 at a 13.61% CAGR. Leading biotech companies including Amgen, Gilead, Regeneron, Vertex, and Moderna reported strong Q3 2026 results with revenue growth ranging from 8% to 36%. The sector experienced record dealmaking activity with major acquisitions totaling tens of billions of dollars, driven by patent expiries, strong cash flows, and strategic pipeline expansion in oncology, immunology, and advanced therapies.
Ways to Trade MRK at MEXC
How to Buy Merck & Co., Inc. (MRK) Stock on MEXC
Eligible investors can buy real shares of Merck & Co., Inc. (MRK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Merck & Co., Inc. (MRK) stock price today?
2.Is MRK stock going up or down today?
3.What is MRK pre-market price?
4.What is MRK after-hours price?
5.Is MRK stock trading now?
6.Where does MRK sit relative to its 52-week high and low?
7.What sector is Merck & Co., Inc. in?
8.What is Merck & Co., Inc.'s market capitalization and where is it listed?
9.How is MRK valued in terms of P/E ratio and EPS?
10.Does Merck & Co., Inc. pay a dividend?
Explore More US Stocks
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MRK, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
MRK Stock Calculator
Estimate the value between MRK shares and USD.
MRK Shares to USD
1.00 MRK shares = 143.294 USD
Calculations are estimates based on the latest available price and are for reference only.


